Preferred Label : topotecan hydrochloride;

UMLS semantic type : T109 - Organic Chemical; T121 - Pharmacologic Substance;

CAS number : 119413-54-6; 956S425ZCY;

Is substance : O;

UNII : 956S425ZCY;

InChIKey : DGHHQBMTXTWTJV-BQAIUKQQSA-N;

Details


Main resources

You can consult :


http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63612555
2013
France
summary of product characteristics
topotecan hydrochloride
powders
topotecan

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68867734
2013
France
summary of product characteristics
topotecan
topotecan hydrochloride

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68531000
2013
France
summary of product characteristics
topotecan
topotecan hydrochloride
powders

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66352155
2012
France
summary of product characteristics
package leaflet
topotecan hydrochloride
topotecan

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67286943
2012
France
summary of product characteristics
package leaflet
topotecan
topotecan hydrochloride

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65275325
2012
France
summary of product characteristics
package leaflet
topotecan
topotecan hydrochloride

---
http://www.has-sante.fr/portail/display.jsp?id=c_538692
2007
false
France
French
topotecan hydrochloride
cisplatin
Stage IVB Cervical Cancer AJCC v6 and v7
Recurrent Cervical Carcinoma
antineoplastic agents
topotecan
infusions, parenteral
uterine cervical neoplasms
antineoplastic combined chemotherapy protocols
carcinoma
recurrence
treatment outcome
topotecan
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_401027
2006
false
France
French
topotecan hydrochloride
Small cell lung cancer recurrent
antineoplastic agents
enzyme inhibitors
topotecan
infusions, intravenous
neoplasm recurrence, local
treatment outcome
topotecan
small cell lung carcinoma
evaluation of the transparency committee

---
Nous contacter.
05/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.